Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia (CEPHEUS)

This study has been completed.
Sponsor:
Collaborator:
ClinArt Company & Signen Clinical Discoveries
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01025388
First received: December 2, 2009
Last updated: February 7, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)